[
[1] Giannelou M, Mavragani CP. Cardiovascular disease in systemic lupus erythematosus: a comprehensive update. J Autoimmun 2017;82:1–12.10.1016/j.jaut.2017.05.00828606749
]Search in Google Scholar
[
[2] Fava A, Petri M. Systemic lupus erythematosus diagnosis and clinical management. J Autoimmun 2019;96:1–13.10.1016/j.jaut.2018.11.001631063730448290
]Search in Google Scholar
[
[3] Lithuanian Ministry of Health, Health Information Centre of Institute of Hygiene. Number of registered cases by diagnosis in Lithuania in 2018. https://stat.hi.lt/default.aspx?report_id=169.
]Search in Google Scholar
[
[4] Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev 2008;4(2):116–22.10.2174/157340308784245775277935119936286
]Search in Google Scholar
[
[5] Kreps A, Paltoo K, McFarlane I. Cardiac manifestations in systemic lupus erythematosus: a case report and review of the literature. Am J Med Case Rep 2018;6(9):180–3.10.12691/ajmcr-6-9-3628604230533521
]Search in Google Scholar
[
[6] Fosam H. Cardiovascular disease risk in patients with systemic lupus erythematosus. Rheumatology Advisor. Published online 2017.
]Search in Google Scholar
[
[7] Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev 2007;6:379–86.10.1016/j.autrev.2007.01.00317537384
]Search in Google Scholar
[
[8] Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44(10):2331–7.10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I
]Search in Google Scholar
[
[9] Ünlü O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol 2016;3(2):75–84.10.5152/eurjrheum.2015.0085
]Search in Google Scholar
[
[10] Del Papa N, Vaso N. Management of antiphospholipid syndrome. Ther Adv Musculoskelet Dis 2010;4(2):221–7.10.1177/1759720X10365969
]Search in Google Scholar
[
[11] Skamra C, Ramsey-Goldman R. Management of cardiovascular complications in systemic lupus erythematosus. Int J Clin Rheumtol 2010;5(1):75–100.10.2217/ijr.09.73
]Search in Google Scholar
[
[12] Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology (Oxford) 2013;52(12):2108–15.10.1093/rheumatology/ket160
]Search in Google Scholar
[
[13] do Socorro Teixeira Moreira Almeida M, da Costa Arcoverde J, Barros Jacobino MN, Coimbra Neto AR. Male systemic lupus erythematosus, an overlooked diagnosis. Clin Pract 2011;1(4):e103.10.4081/cp.2011.e103398140424765344
]Search in Google Scholar
[
[14] Buleu F, Sirbu E, Caraba A, Dragan S. Heart involvement in inflammatory rheumatic diseases: a systematic literature review. Medicina (Kaunas) 2019;55(6):249.10.3390/medicina55060249663203731174287
]Search in Google Scholar
[
[15] Selzer F, Sutton-Tyrrell K, Fitzgerald S, Tracy R, Kuller L, Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001;37(4):1075–82.10.1161/01.HYP.37.4.1075
]Search in Google Scholar
